17. Multiple system atrophy
107 clinical trials,   153 drugs   (DrugBank: 48 drugs),   59 drug target genes,   104 drug target pathways

Searched query = "Multiple system atrophy", "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02315027
(ClinicalTrials.gov)
October 201231/10/2014Mesenchymal Stem Cell Therapy in Multiple System AtrophyIntrathecal Autologous Mesenchymal Stem Cell Therapy in Multiple System Atrophy (MSA) - Effect of Dose and Natural HistoryMSABiological: autologous mesenchymal stem cellsMayo ClinicNULLActive, not recruiting30 Years80 YearsAll30Phase 1United States
2NCT00911365
(ClinicalTrials.gov)
May 200826/5/2009Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System AtrophyA Double-blind Placebo-controlled Randomized Clinical Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System AtrophyMultiple System AtrophyBiological: autologous mesenchymal stem cells;Biological: normal salineYonsei UniversityNULLCompletedN/A75 YearsBoth27Phase 2Korea, Republic of